Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 605-608

  Inagi, Reiko ^a   Nangaku, Masaomi ^b   Miyata, Toshio ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Experimental animal model; Mesangial cells; Receptor for AGE; Serpin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBONYL DERIVATIVE; CELL ADHESION MOLECULE; CYTOKINE; GROWTH FACTOR; MEGSIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MESANGIUM; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYNTHESIS; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 23744497959     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1338.068     Document Type: Conference Paper

References (20)

1. MIYATA, T. & K. KUROKAWA. 2003. A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy. Intern. Med. 42: 1165-1171.
2. MIYATA, T., N. ISHIKAWA & C. VAN YPERSELE DE STRIHOU. 2003. Carbonyl stress and diabetic complications. Clin. Chem. Lab. Med. 41: 1150-1158.
3. MIYATA, T., K. KUROKAWA & C. VAN YPERSELE DE STRIHOU. 2000. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol. 11: 1744-1752.
4. MCLELLAN, A.C., S.A. PHILLIPS & P.J. THORNALLEY. 1992. The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5- dimethoxybenzene. Anal. Biochem. 206: 17-23.
5. GALLOU, G., A. RUELLAND, B. LEGRAS, et al. 1993. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin. Chim. Acta 214: 227-234.
6. HUANO, J.S., J.Y. GUH, H.C. CHEN, et al. 2001. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J. Cell. Biochem. 81: 102-113.
7. MIYATA, T., C. VAN YPERSELE DE STRIHOU, Y. UEDA, et al. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J. Am. Soc. Nephrol. 13: 2478-2487.
8. YASUDA, Y., T. MIYATA, M. NANOAKU, et al. 1998. Functional quantitative analysis of the genome in cultured human mesangial cells. Kidney Int. 53: 154-158.
9. MIYATA, T., M. NANOAKU, D. SUZUKI, et al. 1998. A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J. Clin. Invest. 102: 828-836.
10. INAOI, R., M. NANOAKU, T. MIYATA & K. KUROKAWA. 2003. Mesangial cell-predominant functional gene, megsin. Clin. Exp. Nephrol. 7: 87-92.
11. NANOAKU, M., T. MIYATA, D. SUZUKI, et al. 2001. Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis. Kidney Int. 60: 641-652.
12. SUZUKI, D., T. MIYATA, M. NANOAKU, et al. 1999. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. J. Am. Soc. Nephrol. 10: 2606-2613.
13. MIYATA, T., R. INAOI, M. NANGAKU, et al. 2002. Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J. Clin. Invest. 109: 585-593.
14. SHARMA, K., P. MCCUE & S.R. DUNN. 2003. Diabetic kidney disease in the db/db mouse. Am. J. Physiol. Renal. Physiol. 284: F1138-1144.
15. TOYOTA, E., Y. OGASAWARA, K. FUJIMOTO, et al. 2004. Global heterogeneity of glomerular volume distribution in early diabetic nephropathy. Kidney Int. 66: 855-861.
16. HOSHI, S., Y. SHU, F. YOSHIDA, et al. 2002. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab. Invest. 82: 25-35.
17. JANSSEN, U., S.G. RILEY, A. VASSILIADOU, et al. 2003. Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int. 63: 2162-2170.
18. GROSS, M.L., E. RITZ, A. SCHOOF, et al. 2004. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes. Lab. Invest. 84: 452-464.
19. NANOAKU, M., T. MIYATA, T. SADA, et al. 2003. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J. Am. Soc. Nephrol. 14: 1212-1222.
20. YAMAMOTO, Y., I. KATO, T. DOI, et al. 2001. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108: 261-268.